Evidence map›Paper›PMID 39477891›Full record

ArticleLasers in medical science2024

Combined use of 5-ALA-induced protoporphyrin IX and chlorin e6 for fluorescence diagnostics and photodynamic therapy of skin tumors.

Kanamat Efendiev, Polina Alekseeva, Alexey Skobeltsin, Artem Shiryaev, Tatiana Pisareva, Fatima Akhilgova, Alena Mamedova, Igor Reshetov, Victor Loschenov

Abstract read
PubMed Publisher
In one paragraph

Article in Lasers in medical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kanamat EfendievProkhorov General Physics Institute, Moscow, Russian Federation. kanamatius@gmail.com.
Polina AlekseevaProkhorov General Physics Institute, Moscow, Russian Federation.
Alexey SkobeltsinProkhorov General Physics Institute, Moscow, Russian Federation.
Artem ShiryaevSechenov University, Moscow, Russian Federation.
Tatiana PisarevaSechenov University, Moscow, Russian Federation.
Fatima AkhilgovaSechenov University, Moscow, Russian Federation.
Alena MamedovaSechenov University, Moscow, Russian Federation.
Igor ReshetovSechenov University, Moscow, Russian Federation.
Victor LoschenovProkhorov General Physics Institute, Moscow, Russian Federation.

Funding

Ministry of Education and Science of the Russian Federation 075-15-2022-315
6 · The paper itself

Abstract

Different types of photosensitizers (PSs) have different dynamics and intensities of accumulation, depending on the type of tumor or different areas within the same tumor. This determines the effectiveness of fluorescence diagnostics and photodynamic therapy (PDT). This paper studies the processes of 5-aminolevulinic acid (5-ALA)-induced protoporphyrin IX (PpIX) and chlorin e6 (Ce6) accumulation in the central and border zones of a tumor after combined administration of two PSs into the patient's body. Fluorescence diagnostic methods have shown that sublingual administration of 5-ALA leads to the more intense accumulation of PpIX in a tumor compared to oral administration. Differences have been identified in the dynamics of 5-ALA-induced PpIX and Ce6 accumulation in the central and border zones of the tumor, as well as normal tissues. Ce6 accumulates mainly in the central zone of the tumor while PpIX accumulates in the border zone of the tumor. All patients with combined PDT experienced complete therapeutic pathomorphosis and relapse-free observation.

Indexed as

Aminolevulinic AcidChlorophyllidesPhotochemotherapyPhotosensitizing AgentsPorphyrinsProtoporphyrinsSkin NeoplasmsAgedFemaleFluorescenceHumansMaleMiddle AgedAminolevulinic AcidChlorophyllidesPhotosensitizing AgentsphytochlorinPorphyrinsprotoporphyrin IXProtoporphyrins5-aminolevulinic acidChlorin e6Fluorescence diagnosticsPhotodynamic therapyPhototheranosticsProtoporphyrin IXSkin tumors

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.